116 related articles for article (PubMed ID: 6270261)
1. A hybridoma cell line secreting antibody to poliovirus type 3 D-antigen: detection in virus harvest of two D-antigen populations.
Ferguson M; Schild GC; Minor PD; Yates PJ; Spitz M
J Gen Virol; 1981 Jun; 54(Pt 2):437-42. PubMed ID: 6270261
[TBL] [Abstract][Full Text] [Related]
2. Antigenic analysis of poliovirus type 3 using monoclonal antibodies.
Ferguson M; Minor PD; Magrath DI; Schild GC
Dev Biol Stand; 1984; 57():151-5. PubMed ID: 6098495
[TBL] [Abstract][Full Text] [Related]
3. Neutralization epitopes on poliovirus type 3 particles: an analysis using monoclonal antibodies.
Ferguson M; Minor PD; Magrath DI; Qui YH; Spitz M; Schild GC
J Gen Virol; 1984 Jan; 65 ( Pt 1)():197-201. PubMed ID: 6198447
[TBL] [Abstract][Full Text] [Related]
4. Reactivity of anti-peptide and anti-poliovirus type 3 monoclonal antibodies with synthetic peptides.
Ferguson M; Reed SE; Minor PD
J Gen Virol; 1986 Nov; 67 ( Pt 11)():2527-31. PubMed ID: 2431104
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies reactive with different sites of N and H antigenic particles of poliovirus.
Taniguchi K; Urasawa S; Urasawa T
J Gen Virol; 1983 Dec; 64 ( Pt 12)():2803-8. PubMed ID: 6198442
[TBL] [Abstract][Full Text] [Related]
6. [Establishment of 25 hybridomas secreting monoclonal antibodies against type 1 polio viruses (Sabin strain) and their application in antigenic analysis].
Gu FZ; Mu GF; Wang YA
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Jun; 6(3):157-61. PubMed ID: 6098380
[No Abstract] [Full Text] [Related]
7. Hybridoma cell lines secreting monoclonal antibodies to foot-and-mouth disease virus type Asia-1.
Butchaiah G; Rao BU
Acta Virol; 1989 Mar; 33(2):121-30. PubMed ID: 2569807
[TBL] [Abstract][Full Text] [Related]
8. Production and potential use of monoclonal antibodies against polio viruses.
Osterhaus AD; van Wezel AL; van Steenis G; Hazendonk AG; Drost G
Dev Biol Stand; 1981; 50():221-8. PubMed ID: 6281107
[TBL] [Abstract][Full Text] [Related]
9. Antigenic characterization of poliovirus type 3 using monoclonal antibodies.
Ferguson M; Minor PD; Magrath DI; Spitz M; Schild GC
Rev Infect Dis; 1984; 6 Suppl 2():S510-3. PubMed ID: 6204368
[TBL] [Abstract][Full Text] [Related]
10. Use of monoclonal antibodies prepared with Sabin vaccine viruses for the characterization of poliovirus strains isolated in Canada.
Wachmann B; Henning D; Armstrong R; Boucher DW; Contreras G; Furesz J
Dev Biol Stand; 1984; 57():141-9. PubMed ID: 6084605
[TBL] [Abstract][Full Text] [Related]
11. A human-human hybridoma which produces antibodies to polioviruses.
Chu CT; Yang SY; Yang CS
Proc Natl Sci Counc Repub China B; 1989 Oct; 13(4):284-8. PubMed ID: 2561573
[TBL] [Abstract][Full Text] [Related]
12. Differences in conformation of type 3 poliovirus antigenic sites on non-infectious empty particles and infectious virus.
Ferguson M; Minor PD
J Gen Virol; 1990 Jun; 71 ( Pt 6)():1271-4. PubMed ID: 1693661
[TBL] [Abstract][Full Text] [Related]
13. Production of anti-tumor human monoclonal antibodies using different approaches.
Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
[TBL] [Abstract][Full Text] [Related]
14. In vitro stimulation of presensitized mouse spleen cells with poliovirus type 1, Mahoney, and enhancement of poliovirus-specific hybridomas.
Wiegers KJ; Uhlig H; Dernick R
J Gen Virol; 1986 Sep; 67 ( Pt 9)():2053-7. PubMed ID: 3018136
[TBL] [Abstract][Full Text] [Related]
15. Genetic and antigenic variation in type 3 polioviruses: characterization of strains by monoclonal antibodies and T1 oligonucleotide mapping.
Minor PD; Schild GC; Ferguson M; Mackay A; Magrath DI; John A; Yates JP; Spitz M
J Gen Virol; 1982 Aug; 61 (Pt 2)():167-76. PubMed ID: 6181190
[TBL] [Abstract][Full Text] [Related]
16. Improved distribution of antigenic site specificity of poliovirus-neutralizing antibodies induced by a protease-cleaved immunogen in mice.
Roivainen M; Montagnon B; Chalumeau H; Murray M; Wimmer E; Hovi T
J Virol; 1990 Feb; 64(2):559-62. PubMed ID: 1688625
[TBL] [Abstract][Full Text] [Related]
17. Immunochemical studies of polioviruses: identification of immunoreactive virus capsid polypeptides.
Thorpe R; Minor PD; Mackay A; Schild GC; Spitz M
J Gen Virol; 1982 Dec; 63(2):487-92. PubMed ID: 6185628
[TBL] [Abstract][Full Text] [Related]
18. Determination of type 1 poliovirus subtype classes with neutralizing monoclonal antibodies.
Crainic R; Couillin P; Cabau N; Boue A; Horodniceanu F
Dev Biol Stand; 1981; 50():229-34. PubMed ID: 6176486
[TBL] [Abstract][Full Text] [Related]
19. Different virus-precipitating activities of neutralizing monoclonal antibodies that recognize distinct sites of poliovirus particles.
Taniguchi K; Urasawa S
Arch Virol; 1987; 92(1-2):27-40. PubMed ID: 2432854
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies reveal in blocking reactions the antigenicity and antibody response of poliovirus.
Uhlig H; Rutter G; Dernick R
Dev Biol Stand; 1984; 57():187-91. PubMed ID: 6084610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
